3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
Conditions
Skin Neoplasms
2
Myelodysplastic Syndromes
2
Prostatic Neoplasms
1
Neoplasms
1
Myofibroma
1
Multiple Endocrine Neoplasia Type 1
1
Motor Activity
1
Limb-girdle muscular dystrophy, type 2C
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Intraocular Lymphoma
1
Inflammation
1
Hemorrhage
1
Eye Diseases
1
Diabetes Mellitus, Type 2
1
Diabetes Mellitus
1
Cytopenia
1
Corneal Endothelial Cell Loss
1
Colorectal Neoplasms
1
Cognitive Dysfunction
1
Cataract
1
Cardiovascular Diseases
1
Breast Neoplasms
1
Adenomyosis
1
Interventions
Transcranial Direct Current Stimulation
4
Exercise
4
Walking
3
Methods
2
Cognitive Behavioral Therapy
2
blueberry extract
1
beta Carotene
1
Vitamin E
1
Ultraviolet Therapy
1
Transcranial Magnetic Stimulation
1
Time
1
Therapeutics
1
Tai Ji
1
Tablets
1
Standard of Care
1
Rehabilitation, Vocational
1
Referral and Consultation
1
Population Groups
1
Physical Conditioning, Human
1
Palliative Care
1
Organization and Administration
1
Mindfulness-Based Stress Reduction
1
Mindfulness
1
Low-Level Light Therapy
1
Health
1
Geritol
1
Geriatric Assessment
1
Exergaming
1
Equine-Assisted Therapy
1
Employment, Supported
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Cognitive Dysfunction
×
Ascorbic Acid
×
Clear all
NCT00270647
2018-02-28
PHS II
Brigham and Women's Hospital
Phase NA
Completed
14,641 enrolled